Down Syndrome
Pipeline by Development Stage
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (9)
Total enrollment: 197 patients across 9 trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A Study of ACI-24 in Adults With Down Syndrome
A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.
Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial
Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
Impact of an Orthotic Garment on Gross Motor Skills for Infants With Down Syndrome
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)